Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Been-There-Done-That Biotech CEOs Who Are Doing it Again

TheMotleyFool 
0 0 21.07.17
3 Been-There-Done-That Biotech CEOs Who Are Doing it Again
 
3 Been-There-Done-That Biotech CEOs Who Are Doing it Again

You might want to turn back the clock so that you can profit from Puma Biotechnology's (NASDAQ: PBYI) 212% return this year, but unfortunately, you can't. Instead, you'll just have to go out and find the next big biotech winner -- and to manage that, you're going to have to do your homework.

Fortunately, The Motley Fool's Kristine Harjes and Todd Campbell are here to help! In today's episode of The Motley Fool's Industry Focus: Healthcare podcast, the two discuss how Puma Biotechnology's experienced management team helped it deliver a big win, and why proven leaders at Aurinia Pharmaceuticals (NASDAQ: AUPH), Axovant Sciences (NYSE: AXON), and Esperion Therapeutics (NASDAQ: ESPR) might someday deliver similar success.

A full transcript follows the video.

Continue reading


Source: Fool.com

Puma Biotechnology Inc. Stock

€2.15
0.090%
With only a change of €0.002 (0.090%) the Puma Biotechnology Inc. price is nearly unchanged from yesterday.

Show more
Like: 0
PBYI
Share

Comments

Not a member yet? Sign up for free!